Trade Mark Journal No.2026/007 13 February 2026

UK00004331906 29 January 2026 (5)

REYAROS

International priority date claimed: 11 August 2025 (United States of America) (99331143)

Class 5: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations .

Juno Therapeutics, Inc.

Representative: Sipara Limited